Secondly, we only examined the changes in the expression of inflammatory factors and the Sirt1/NF-κB signaling pathway in hippocampal regions and did not evaluate the changes in these indicators in other anxiety- and depression-related brain regions, such as the amygdala. Here, SIRT1 is linked to depressive symptom measurement.